Company intelligence / Profile preview

999 Brand

Shenzhen, Guangdong, China
Ownership
Private
Employees
~25000
Development stage
Other
01

Overview

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (CR Sanjiu) is a leading Chinese pharmaceutical company specializing in the research, development, and manufacturing of over-the-counter (OTC) drugs and Traditional Chinese Medicine (TCM). The company is most famous for its 999 brand, which maintains a dominant market share in China for cold and flu remedies, gastrointestinal treatments, and dermatological products. Beyond its consumer health leadership, CR Sanjiu operates a robust prescription drug division focusing on anti-infectives, cardiovascular health, and oncology. As a core subsidiary of the state-owned China Resources Group, the company utilizes an extensive national distribution network and advanced manufacturing facilities. CR Sanjiu is increasingly investing in innovative drug development, including biologics and small molecules, through internal R&D and strategic global partnerships.

Therapeutic areas
CardiovascularNeurologyDermatologyInfectious DiseasesPulmonologyGastroenterologyOncology
Modalities
Small moleculeTraditional Chinese MedicineMonoclonal antibodyRecombinant protein
Industry
Pharma
02

Partnerships

OncoC4Tasly Pharmaceutical

Beyond the preview

Go deeper on 999 Brand.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 999 Brand.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call